GPX3 and neoplasm: Epigenetic hypermethylation and genome deletion are reported as two reasons for the down-regulation of GPx3 during cancer development [7, 8, 26, 27], but the mechanism of down-regulation of GPx3 contributing to tumor progression remains to be investigated.